QuarterlyIQ Insights · BSX
Factors
The full factor breakdown (the numbers behind each rank). The overview page shows the same reads in short form; this is the depth.
Factor signals
Each factor is a parallel diagnostic with a plain-language read of what it shows and how names like it have historically fared. Never aggregated into a single score.
Operating income rose in 2 of the last 3 quarter-over-quarter moves. Historically, Health Care names rated strong grew net income 59% of the time over the next year (vs 52% for the rest of the cohort, n=2344).
The numbers
Over the trailing year it converted 1.22x of net income into operating cash flow. Historically, Health Care names rated fragile grew net income 40% of the time over the next year (vs 56% for the rest of the cohort, n=1703).
The numbers
Most sensitive to the broad stock market.
- the broad stock market: This stock moves with the broad market (high beta).β 0.60 · R² 0.11
Not enough signal to read sensitivity to Fed net liquidity, real (inflation-adjusted) rates, the US dollar, long-term interest rates (low R² over the window).
12 material management or governance events in the past 24 months, led by executive changes. Historically, Health Care names rated volatile grew net income 43% of the time over the next year (vs 57% for the rest of the cohort, n=600).
The numbers
Not investment advice. As of 2026-06-09.
Earnings setup & market context
The next print and the backdrop around it (sector regime and the AI cycle). Context for the path, not a forecast of returns.
Why this setup
EPS estimate $0.83 → $0.83 (-0.3% / 30d). 1 raised, 7 cut, 24 covering analysts.
0 upgrades, 2 downgrades / 30d, 10 maintained. 87% of analysts rate Buy.
10 PT revisions / 30d. Avg target 40.3% above current price.
2 positive, 0 negative / 30d. See F4 management tile for the event list.
via XLV
Tailwind = sector leading the S&P 500; headwind = trailing. Both can be constructive. Historically, headwind regimes have averaged stronger forward returns than tailwind.
Context label only: describes the market state (e.g. real bear vs narrative panic, healthy uptrend vs late-stage froth). It is not a per-ticker buy/sell signal and does not predict factor performance.
Not investment advice. As of 2026-06-09.